Construction. 4QFY18E Results Preview 14 APR Parikshit D Kandpal

Similar documents
Construction & Infra. 1QFY19E Results Preview 10 JUL Parikshit D Kandpal

Real Estate. 3QFY19E Results Preview. 11 Jan Parikshit D Kandpal, CFA

Capital Goods. 3QFY18E Results Preview. 10 Jan Sujit Jain

Agrochemicals. 3QFY18E Results Preview 09 JAN Basanth Patil

J. Kumar Infraprojects

Dilip Buildcon. Strong comeback BUY RESULT REVIEW 1QFY19 16 AUG Highlights of the quarter. CMP (as on 16 Aug 2018) Rs 847 Target Price Rs 1,434

Agriculture. 4QFY18E Results Preview 13 APR Madhukar Ladha

J. Kumar Infraprojects

PSP Projects. Marginal miss BUY RESULTS REVIEW 1QFY19 10 AUG 2018

Real Estate. 4QFY17E Results Preview. 13 Apr Parikshit D Kandpal

Jubilant FoodWorks NEUTRAL RESULTS REVIEW 4QFY17 30 MAY Highlights of the quarter

Jubilant FoodWorks BUY RESULTS REVIEW 1QFY18 18 JULY Highlights of the quarter

Ahluwalia Contracts. Cautious optimism BUY RESULTS REVIEW 4QFY17 31 MAY Highlights of the quarter

Weak quarter but well placed

Healty cigarette-driven growth

BLS International Services

Crompton Greaves Consumer Electricals

Crompton Greaves Consumer Electricals

Navin Fluorine International

Neuland Labs BUY RESULTS REVIEW 1QFY19 12 AUG 2018

Intellect Design Arena

Oil & Gas. 4QFY17E Results Preview. 13 Apr Deepak Kolhe

Outperformance continues

Multi Commodity Exchange

ICICI Prudential Life

Kalpataru Power Transmission

Max Financial. Improving margins! BUY RESULTS REVIEW 4QFY18 30 MAY Highlights of the quarter

Discounting $45/bbl of realisation

NRB Bearings. Strong Show BUY RESULTS REVIEW 4QFY18 23 MAY Highlights of the quarter

BHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188

Chemicals and Fertilisers

Gulf Oil Lubricants BUY RESULTS REVIEW 1QFY19 09 AUG Key highlights

PI Industries BUY RESULTS REVIEW 1QFY19 07 AUG Highlights of the quarter

Near-term pressure, but long-term outlook positive

Torrent Pharma BUY RESULTS REVIEW 1QFY18 01 AUG 2017

Central Depository Services

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

Alkem Labs BUY RESULTS REVIEW 1QFY19 11 AUG story remains on-track. Maintain BUY with a revised TP of Rs 2,410 (24x FY20E EPS).

Central Depository Services

Music Broadcast. In-line but muted BUY RESULTS REVIEW 2QFY19 26 OCT Key highlights. CMP (as on 26 Oct 2018) Rs 328 Target Price Rs 387

Sun Pharma BUY RESULTS REVIEW 1QFY19 16 AUG 2018

Hindustan Unilever BUY RESULTS REVIEW 4QFY17 18 MAY 2017

Carborundum Universal

Vinati Organics BUY RESULTS REVIEW 2QFY19 29 OCT INDUSTRY CHEMICALS CMP (as on 29 Oct 2018) Rs 1,408 Target Price Rs 1,700

Central Depository Services

Pre-sales pickup key trigger

Mahanagar Gas BUY RESULTS REVIEW 1QFY19 01 AUG Highlights of the quarter. CMP (as on 1 Aug 2018) Rs 947 Target Price Rs 1,292

Brigade Enterprises. Stable performance BUY RESULTS REVIEW 2QFY19 14 NOV 2018

Alkem Labs BUY RESULTS REVIEW 3QFY19 09 FEB CMP (as on 08 Feb 2019) Rs 1,904 Target Price Rs 2,340. Highlights of the quarter

ITD Cementation (India) Ltd.

Exide Industries BUY RESULTS REVIEW 4QFY18 08 MAY Highlights of the quarter. CMP (as on 08 May 2018) Rs 268 Target Price Rs 298

Jubilant Life Sciences

Maruti Suzuki. A Trough Quarter BUY RESULTS REVIEW 3QFY19 25 JAN CMP(as on 25 Jan 2019) Rs 6,516 Target Price Rs 7,400

IRB Infrastructure Developers

Dr. Reddy s Labs. Misery continues SELL RESULTS REVIEW 1QFY18 28 JUL 2017

Hindustan Petroleum Corporation

Dishman Carbogen Amcis

Geared for version 3.0

Pharmaceuticals. 2QFY19 Results Preview. 10 Oct Amey Chalke

Bharti Infratel BUY RESULT REVIEW 3QFY19 25 JAN 2019

Ambuja Cement. Realisations-driven beat SELL RESULTS REVIEW 2QCY17 25 JUL Highlights of the quarter

Strong volumes, offset by costs

Hindustan Petroleum Corporation

Cement, Metals & Mining

IRB Infrastructure Developers

Crompton Greaves Consumer Electricals

Radico Khaitan BUY RESULTS REVIEW 3QFY19 24 JAN 2019

Margin boost through non-core book

Tata Steel. JV comes to fruition BUY COMPANY UPDATE 21 SEP Other key highlights. CMP (as on 20 Sep 17) Rs 688 Target Price Rs 818

Hero MotoCorp BUY RESULTS REVIEW 2QFY19 16 OCT CMP (as on 16 Oct 2018) Rs 2,898 Target Price Rs 3,602. Highlights of the quarter

Bajaj Auto BUY RESULTS REVIEW 1QFY18 21 JUL Highlights of the quarter

Subros BUY RESULTS REVIEW 2QFY19 30 OCT CMP (as on 29 Oct 2018) Rs 268 TP Rs 435. Key highlights

NIIT Technologies. NEUTRAL Higher capex weighing on FCF RESULTS REVIEW 2QFY15 16 OCT 2014

Bharat Petroleum Corporation

Reliance Industries. Timing is everything BUY COMPANY UPDATE 1 OCT 2014

Sonata Software. On growth path BUY RESULTS REVIEW 1QFY18 16 AUG Highlights of the quarter

Navin Fluorine International

JBM Auto. Ready to take off BUY RESULTS REVIEW 1QFY19 07 AUG Key highlights

Mphasis. Growth drivers intact BUY RESULTS REVIEW 3QFY19 25 JAN 2019

Insecticides India BUY RESULTS REVIEW 4QFY17 30 MAY 2017

Multi Commodity Exchange

Lupin BUY COMPANY UPDATE 12 SEP 2013

Residential recovery awaited

ITC BUY RESULTS REVIEW 1QFY19 27 JUL 2018

Weak show, DCCDL key trigger

Weak numbers in peak quarter

Emami NEUTRAL RESULTS REVIEW 4QFY15 14 MAY 2015

Autos. 4QFY18E Results Preview. 12 Apr Abhishek Jain

Bajaj Auto NEUTRAL RESULTS REVIEW 2QFY16 23 OCT Key highlights. CMP (as on 23 Oct 2015) Rs 2,514 Target Price Rs 2,720

V-Guard BUY RESULTS REVIEW 3QFY19 02 FEB 2019

Growth + cash flows = BUY

FIRSTSOURCE SOLUTIONS LTD.

BUY. Robust quarter with clear growth visibility DILIP BUILDCON. Target Price: Rs 610. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E

Suprajit Engineering. Synergies to accrue BUY COMPANY UPDATE 16 SEP 2016

Cyient. Good show, priced in NEUTRAL RESULTS REVIEW 4QFY17 21 APRIL Highlights of the quarter

Pharmaceuticals. 4QFY18 Results Preview. 13 Apr Amey Chalke

Bharat Forge. Cyclical headwinds persist but structural story intact BUY COMPANY UPDATE 9 DEC Key takeaways

Coromandel International

Mindtree. Steady quarter, Upside capped NEUTRAL RESULTS REVIEW 4QFY19 18 APR INDUSTRY CMP (as on 16 Apr 2019) Rs 972 Target Price Rs 1,040

Karur Vysya Bank BUY RESULTS REVIEW 1QFY19 26 JUL 2018

Transcription:

Construction 4QFY18E Results Preview 14 APR 2018 Parikshit D Kandpal parikshit.kandpal@hdfcsec.com +91-22-6171 7317 Kunal Bhandari kunal.bhandari@hdfcsec.com +91-22-6639 3035

4QFY15 1QFY16 2QFY16 3QFY16 4QFY16 1QFY17 2QFY17 3QFY17 4QFY17 1QFY18 2QFY18 3QFY18 4QFY18E 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 3QFY16 4QFY16 1QFY17 2QFY17 3QFY17 4QFY17 1QFY18 2QFY18 3QFY18 4QFY18E 4QFY18E RESULTS PREVIEW Construction (4QFY18E): Recovery well placed Record ordering in 4QFY18, focus to shift towards execution: NHAI increased the awarding pace in 4QFY18 post a muted 9MFY18 taking aggregate awards to ~7,400km. With EPC players order backlogs swelling, we expect focus to shift towards execution. NHAI is targeting another ~7,000-8,000km of awards for FY19E with Rs 1.2tn of combined value, order visibility is strong. Besides road, vertical, Buildings segment outlook remains buoyant led by institutional, government and retail/hospitality led spending. EPC companies book to bill comfortable at 4x FY18E revenue: Our coverage universe book to bill has increased to 4x on FY18E revenues, helped by the accelerated pace of NHAI tendering. We believe the current backlog lends sufficient growth visibility. Net D/E is comfortable at 0.37x (at decade low) and NWC days is stable at 125days. 4QFY18E to set tone for recovery, execution key for further rerating: We expect aggregate revenue for our coverage universe to grow 19.2% YoY as new order wins have moved into execution. Aggregate EBIDTA is expected to grow 3.4% YoY on back of lower margins in legacy order book and no one-off cost provsions reversals. Aggregate PAT would grow 28.8% led by lower interest rate and MAT benefit. We expect higher double digit YoY earnings recovery for our coverage universe from 4QFY18E and earnings traction is likely to build positively in ensuing quarters. Execution is key for further re-rating. Top Picks: Ashoka Buildcon, PNC Infra, JKIL & JMC Projects. Aggregate Earnings Recovery 140 120 100 80 60 40 20 - Aggregate Growth Metrics 100.0 80.0 60.0 40.0 20.0 0.0-20.0 Sales (Rs bn) EBITDA (Rs bn) EBITDA Margins - RHS 25 Sales Growth YoY EBITDA Growth YoY Net Profit Growth YoY Source: HDFC sec Inst Research 20 15 10 5 0 2

4QFY18E: Recovery well placed COMPANY 4QFY18E OUTLOOK WHAT S LIKELY KEY MONITORABLES We expect 26.7% YoY revenue growth Capex and further guidance for FY19E Dilip Buildcon EBIDTA to grow 11.5% YoY to Rs 4.0bn Strong PAT growth of 44.2%YoY expected on back of receipt of early completion bonus Commentary on funding equity for HAM Debt levels We expect 21.4% YoY revenue de-growth on de-consolidation Commentary on consolidated debt levels IRB Infra AVG EBIDTA margins to contract 705bps to 43.5%. Higher share from EPC. EBIDTA to de-grow 32.4% YoY PAT to de-grow 6.9% YoY Financial closure for HAM projects Update on toll growth NCC Expect revenue growth of 21% YoY EBIDTA margins to expand 97.7bps YoY to 9.1% Net profit to grow 7.6% YoY. We have not factored in any exceptional loss on account of real estate monetization Progress on real estate asset monetisation Debt levels Working capital cycle Sadbhav Engineering AVG Expect 10.7% YoY revenue growth EBIDTA margins to expand 82.6bps YoY to 11.4% PAT to grow 4.5% YoY Commentary on bidding for elevated Metro projects Debt levels HAM financial closure Expect 95.2% YoY growth in revenues as the entire backlog is on the cusp of moving into execution Financial closure of Jhansi-Khajurao (Pkg I) and Appoined date for Bhojpur Buxar PNC Infratech Expect EBITDA margin of 13.7% Net profit to grow 291.1% YoY on the back of increased execution and early completion bonus in Lucknow Ballia of Rs 0.6bn Updates on BOT monetization plans Bidding pipeline 3

4QFY18E: Recovery well placed COMPANY 4QFY18E OUTLOOK WHAT S LIKELY KEY MONITORABLES We expect revenue growth of 26.3% YoY EPC order intake Ashoka Buildcon AVG Expect EBIDTA margins of 12.2% (+181bps YoY) PAT to decline 11% YoY on higher taxes Toll collection growth Update on financial closure of HAM projects KNR Constructions AVG We expect 3.6% YoY revenue growth Expect EBIDTA margins of 19.4% as impact of provision reversals expected in 4QFY18E as well Net profit to decline 13.9% YoY on higher taxes lower OI Order intake Commentary on further bidding in HAM projects BOT assets monetization ITD Cementation We expect revenue growth of 12% YoY EBIDTA margins to decline by 343.5bps YoY to 11.1% APAT to grow 103.1% YoY on addition of associate profits Updates on Bangalore and Mumbai metro projects Commentary on bidding in marine/ irrigation segment Management outlook on bidding for HAM projects Ahluwalia Contracts We expect revenue decline of 2.1% YoY EBIDTA margins to expand 444bps YoY to 13.6% APAT to grow 59.9% YoY Comments on bidding pipeline and competitive intensity in building segment Update on margin trajectory J Kumar Infraprojects We estimate 98.7% YoY revenue growth driven by Metro and JNPT projects EBIDTA margins may decline by 145bps YoY and rationalize to 15.5% APAT to grow 38.4% YoY Revenue from MRTS projects New order inflow guidance Debt levels and status of pending Rs 1bn mob. adv. for line 3 4

4QFY18E: Recovery well placed COMPANY 4QFY18E OUTLOOK WHAT S LIKELY KEY MONITORABLES Expect 10.2% YoY growth in revenues driven by buildings segment Commentary on restructuring in BOT projects and estimated loss funding JMC Projects Expect EBITDA margin of 10.1% Net profit to increase 53.4% YoY Update on L1 status in international infra projects Guidance on debt levels PSP Projects We expect 52.2% QoQ revenue growth on recognition from SDB project Expect EBIDTA margins of 11.1% Net profit to grow 22.5% QoQ to Rs 0.2bn Execution pace in the SDB project Commentary on bidding pipeline Update on fund receipts from SDB 5

4QFY18E: Financial summary NET REVENUES (Rs bn) EBITDA (Rs bn) EBITDA Margin APAT (Rs bn) Adj. EPS (Rs/sh) COMPANY 4Q FY18E QoQ YoY 4Q FY18E QoQ YoY 4Q FY18E QoQ (bps) YoY (bps) 4Q FY18E QoQ YoY 4Q FY18E 2Q FY18 3Q FY17 Dilip Buildcon 22.18 14.2 26.7 3.96 14.7 11.5 17.8 8.1 (243.7) 2.82 71.5 44.2 20.6 12.0 14.3 IRB Infra Developers* 12.79 (1.3) (21.4) 5.56 (11.9) (32.4) 43.5 (518.3) (705.4) 1.92 (7.5) (6.9) 5.5 5.9 5.9 NCC 25.89 39.9 21.0 2.36 (7.5) 35.5 9.1 (467.2) 97.7 1.20 (8.4) 7.6 2.0 2.2 1.8 Sadbhav Engineering 11.43 22.2 10.7 1.31 23.7 19.3 11.4 13.3 82.6 0.71 34.0 4.5 4.2 3.1 4.0 PNC Infratech 6.84 44.8 95.2 0.94 41.6 98.0 13.7 (30.9) 19.2 1.33 206.6 291.1 5.2 1.7 1.3 Ashoka Buildcon 7.71 17.0 26.3 0.94 18.5 48.2 12.2 16.1 180.6 0.59 12.8 (11.0) 3.1 2.8 3.5 KNR Constructions 5.00 15.3 3.6 0.97 (1.7) 34.0 19.4 (335.3) 438.1 0.45 (31.4) (13.9) 3.2 4.7 3.7 ITD Cementation * 5.86 2.0 12.0 0.65 (17.1) (14.4) 11.1 (255.2) (343.5) 0.31 (21.7) 103.1 1.8 2.3 0.9 Ahluwalia Contracts 4.62 28.0 (2.1) 0.63 0.5 45.6 13.6 (371.2) 443.9 0.33 11.9 59.9 4.9 4.3 3.0 J. Kumar Infraprojects 7.06 54.5 98.7 1.09 40.7 81.7 15.5 (151.4) (145.0) 0.36 10.2 38.4 4.8 4.4 3.5 JMC Projects 7.61 7.7 10.2 0.77 9.1 30.9 10.1 12.7 159.3 0.27 15.5 53.4 8.2 7.1 5.3 PSP Projects 2.60 52.2 N.A 0.29 9.2 N.A 11.1 (438.6) N.A 0.19 22.5 N.A 5.2 4.2 NA Aggregate 119.60 21.3 19.2 19.46 2.6 3.4 15.6 (295.8) (248.3) 10.47 22.2 28.8 Source: Company, HDFC sec Inst Research *Consolidated, ITD Cementation numbers are for 1Q15MFY19E 6

4QFY18E: Financial summary Company Old Rating New Rating Previous TP (Rs/sh) New TP (Rs/sh) Dilip Buildcon BUY BUY 1,449.0 1,449.0 IRB Infra Developers BUY BUY 313.0 313.0 NCC BUY BUY 155.0 155.0 Sadbhav Engineering BUY BUY 445.0 445.0 PNC Infratech BUY BUY 248.0 248.0 Ashoka Buildcon BUY BUY 348.0 348.0 KNR Constructions BUY BUY 364.0 364.0 ITD Cementation BUY BUY 211.0 211.0 Ahluwalia Contracts BUY BUY 486.0 486.0 J. Kumar Infraprojects BUY BUY 420.0 420.0 JMC Projects BUY BUY 842.0 842.0 PSP Projects BUY BUY 625.0 625.0 Source: HDFC sec Inst Research 7

4QFY18E: Peer Valuation COMPANY MCap (Rs bn) CMP (Rs) RECO TP (Rs) Adj. EPS (Rs/sh) P/E (x) EV/EBITDA (x) ROE FY18E FY19E FY20E FY18E FY19E FY20E FY18E FY19E FY20E FY18E FY19E FY20E Dilip Buildcon 156.0 1,141 BUY 1,449 50.1 63.1 68.6 22.8 18.1 16.6 13.2 10.1 8.1 31.2 29.1 24.2 IRB Infra Developers* 95.6 272 BUY 313 24.8 26.9 24.0 11.0 10.1 11.3 8.8 8.2 8.6 15.6 15.0 12.1 NCC 76.3 127 BUY 155 6.8 6.2 8.1 18.6 20.4 15.7 12.1 9.9 8.3 10.0 8.0 9.5 Sadbhav Engineering 68.4 399 BUY 445 12.4 15.8 16.2 32.1 25.2 24.6 12.7 10.5 8.4 11.5 12.9 11.8 PNC Infratech 45.2 176 BUY 248 4.7 7.6 10.4 37.4 23.2 16.9 12.7 8.8 6.7 7.2 10.3 12.8 Ashoka Buildcon * 49.6 265 BUY 348 2.2 7.6 8.6 120.4 34.8 30.8 10.0 9.3 7.9 2.5 8.3 8.8 KNR Constructions 41.9 298 BUY 364 15.1 12.9 13.9 19.7 23.1 21.5 9.7 9.6 7.9 21.1 14.9 13.7 ITD Cementation * 28.3 165 BUY 211 6.1 10.0 11.7 27.0 16.5 14.1 11.8 8.1 7.1 16.2 19.8 16.5 Ahluwalia Contracts 27.3 407 BUY 486 17.5 21.5 24.6 23.3 18.9 16.5 11.3 9.5 8.2 20.7 20.7 19.4 J. Kumar Infraprojects 21.5 284 BUY 420 15.6 23.4 28.0 18.2 12.1 10.2 7.9 5.6 5.1 8.4 11.7 12.7 JMC Projects 21.5 640 BUY 842 29.1 33.9 40.5 22.0 18.9 15.8 8.7 7.5 6.4 13.3 13.6 14.3 PSP Projects 19.3 536 BUY 625 16.7 27.7 35.5 32.1 19.3 15.1 18.8 11.1 8.3 28.4 28.0 28.4 Average 16.1 20.5 23.2 34.6 22.6 19.7 11.8 9.3 7.9 14.9 15.5 14.9 Source: Company, HDFC sec Inst Research * Consolidated, ITD Cementation FY18E/FY19E should be read as CY17/15MFY19E 8

Rating Definitions BUY NEUTRAL SELL : Where the stock is expected to deliver more than 10% returns over the next 12 month period : Where the stock is expected to deliver (-) 10% to 10% returns over the next 12 month period : Where the stock is expected to deliver less than (-) 10% returns over the next 12 month period Disclosure: We, Parikshit D Kandpal, MBA & Kunal Bhandari, ACA authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. HSL has no material adverse disciplinary history as on the date of publication of this report. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Research Analyst or his/her relative or HDFC Securities Ltd. does not have any financial interest in the subject company. Also Research Analyst or his relative or HDFC Securities Ltd. or its Associate may have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research Report. Further Research Analyst or his relative or HDFC Securities Ltd. or its associate does not have any material conflict of interest. Any holding in stock No HDFC Securities Limited (HSL) is a SEBI Registered Research Analyst having registration no. INH000002475. Disclaimer: This report has been prepared by HDFC Securities Ltd and is meant for sole use by the recipient and not for circulation. The information and opinions contained herein have been compiled or arrived at, based upon information obtained in good faith from sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. This document is for information purposes only. Descriptions of any company or companies or their securities mentioned herein are not intended to be complete and this document is not, and should not be construed as an offer or solicitation of an offer, to buy or sell any securities or other financial instruments. This report is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity who is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject HSL or its affiliates to any registration or licensing requirement within such jurisdiction. If this report is inadvertently send or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. This document may not be reproduced, distributed or published for any purposes without prior written approval of HSL. Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations, which could have an adverse effect on their value or price, or the income derived from them. In addition, investors in securities such as ADRs, the values of which are influenced by foreign currencies effectively assume currency risk. It should not be considered to be taken as an offer to sell or a solicitation to buy any security. HSL may from time to time solicit from, or perform broking, or other services for, any company mentioned in this mail and/or its attachments. HSL and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. HSL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. HSL and other group companies, its directors, associates, employees may have various positions in any of the stocks, securities and financial instruments dealt in the report, or may make sell or purchase or other deals in these securities from time to time or may deal in other securities of the companies / organizations described in this report. HSL or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve months. HSL or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from t date of this report for services in respect of managing or comanaging public offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a merger or specific transaction in the normal course of business. HSL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither HSL nor Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. HSL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of the subject company. We have not received any compensation/benefits from the subject company or third party in connection with the Research Report. HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp. Crompton Greaves, Kanjurmarg (East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022) 2496 5066 Compliance Officer: Binkle R. Oza Email: complianceofficer@hdfcsec.com Phone: (022) 3045 3600 HDFC Securities Limited, SEBI Reg. No.: NSE-INB/F/E 231109431, BSE-INB/F 011109437, AMFI Reg. No. ARN: 13549, PFRDA Reg. No. POP: 04102015, IRDA Corporate Agent License No.: HDF 2806925/HDF C000222657, SEBI Research Analyst Reg. No.: INH000002475, CIN - U67120MH2000PLC152193 Mutual Funds Investments are subject to market risk. Please read the offer and scheme related documents carefully before investing. 9

HDFC securities Institutional Equities Unit No. 1602, 16th Floor, Tower A, Peninsula Business Park, Senapati Bapat Marg, Lower Parel, Mumbai - 400 013 Board : +91-22-6171 7330 www.hdfcsec.com 10